Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mylan
Pharma
Novo settles with Mylan over potential Ozempic generic
Mylan Pharmaceuticals and Novo Nordisk have reached a confidential settlement in a patent lawsuit tied to generic Ozempic, also known as semaglutide.
Fraiser Kansteiner
Oct 7, 2024 9:18am
Viatris, former president cleared in DOJ price-fixing probe
Jul 2, 2024 9:40am
Viatris official Rayapureddy cleared of insider trading charges
Jan 30, 2024 8:30am
Biogen notches another Tecfidera patent win in Europe
Dec 19, 2023 9:30am
FTC takes patent scrutiny to Sanofi, Mylan's insulin case
Nov 21, 2023 11:34am
Another EpiPen antitrust settlement costs Pfizer $50M
Oct 11, 2023 6:03pm
